In case a dose of INCIVEK is missed within 4 hours of the time it is usually taken, patients should be instructed to take the prescribed dose of INCIVEK with food as soon as possible.
If more than 4 hours has passed since INCIVEK is usually taken, the missed dose should NOT be taken and the patient should resume the usual dosing schedule.
Patients should be advised to contact their health care provider if they have questions.
Patients should be advised that they can contact the local Poison Control Center in the event of an overdose.

VERTEX™

Manufactured for
Vertex Pharmaceuticals Incorporated
Cambridge, MA 02139

U.S. Patent No. 7,820,671

©2011 Vertex Pharmaceuticals Incorporated

All rights reserved.

INCIVEK and the Blue Arrow logo are trademarks of Vertex Pharmaceuticals Incorporated. VERTEX and the VERTEX triangle logo are registered trademarks of Vertex Pharmaceuticals Incorporated.

The brands listed are the registered trademarks of their respective owners and are not trademarks of Vertex Pharmaceuticals Incorporated.

MEDICATION GUIDE

INCIVEK (in-SEE-veck)
(telaprevir)
Film-Coated Tablets

Read this Medication Guide before you start taking INCIVEK™ and each time you get a refill. There may be new information. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.

INCIVEK is taken along with peginterferon alfa and ribavirin. You should also read those Medication Guides.

What is the most important information I should know about INCIVEK?

INCIVEK combination treatment may cause serious side effects including:

1.
Birth defects or death of your unborn baby. INCIVEK in combination with peginterferon alfa and ribavirin may cause birth defects or death of your unborn baby. If you are pregnant or your sexual partner is pregnant or plans to become pregnant, do not take these medicines. You or your sexual partner should not become pregnant while taking INCIVEK with peginterferon alfa and ribavirin and for 6 months after treatment is over.
If you are a female who can become pregnant, or you are a female whose male partner takes these medicines:

You must have a negative pregnancy test before starting treatment, each month during treatment, and for 6 months after your treatment ends.
You must use 2 forms of effective birth control during treatment and for the 6 months after treatment with these medicines. Hormonal forms of birth control including birth control pills, vaginal rings, implants, or injections may not work during treatment with INCIVEK. You could become pregnant. Talk to your healthcare provider about other forms of birth control that may be used during this time. If your healthcare provider tells you to stop taking INCIVEK, peginterferon alfa and ribavirin, you must still use two forms of birth control for the 6 months after treatment with these medicines. You may use a hormonal form of birth control as one of your two forms of birth control after 2 weeks of stopping INCIVEK.
If you or your female sexual partner becomes pregnant while taking INCIVEK, peginterferon alfa, and ribavirin or within 6 months after you stop taking these medicines, tell your healthcare provider right away. You or your healthcare provider should contact the Ribavirin Pregnancy Registry by calling 1-800-593-2214. The R